The Professional Counselor | Volume 12, Issue 2 121 Rashrash, M., Schommer, J. C., & Brown, L. M. (2017). Prevalence and predictors of herbal medicine use among adults in the United States. Journal of Patient Experience, 4(3), 108–113. https://doi.org/10.1177/2374373517706612 Ravina, E. (2011). The evolution of drug discovery: From traditional medicines to modern drugs. Wiley. Ravven, S. E., Zimmerman, M. B., Schultz, S. K., & Wallace, R. B. (2011). 12-month herbal medicine use for mental health from the National Comorbidity Survey Replication (NCS-R). Annals of Clinical Psychiatry, 23(2), 83–94. Sakurai, H., Carpenter, L. L., Tyrka, A. R., Price, L. H., Papakostas, G. I., Dording, C. M., Yeung, A. S., Cusin, C., Ludington, E., Bernard-Negron, R., Fava, M., & Mischoulon, D. (2020). Dose increase of S-adenosylmethionine and escitalopram in a randomized clinical trial for major depressive disorder. Journal of Affective Disorders, 262, 118–125. https://doi.org/10.1016/j.jad.2019.10.040 Saran, J. S., Barbano, R. L., Schult, R., Wiegand, T. J., & Selioutski, O. (2017). Chronic diphenhydramine abuse and withdrawal: A diagnostic challenge. Neurology: Clinical Practice, 7(5), 439–441. https://doi.org/10.1212/CPJ.0000000000000304 Sarris, J. (2007). Herbal medicines in the treatment of psychiatric disorders: A systematic review. Phytotherapy Research, 21(8), 703–716. https://doi.org/10.1002/ptr.2187 Sarris, J. (2018). Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review. Phytotherapy Research, 32(7), 1147–1162. https://doi.org/10.1002/ptr.6055 Savage, K., Firth, J., Stough, C., & Sarris, J. (2018). GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. Phytotherapy Research, 32(1), 3–18. https://doi.org/10.1002/ptr.5940 Savage, R. A., Basnet, S., & Miller, J. M. (2020). Melatonin. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/ books/NBK534823 Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019). Serotonin syndrome: Pathophysiology, clinical features, management, and potential future directions. International Journal of Tryptophan Research, 12, 1–14. https://doi.org/10.1177/1178646919873925 Sepulveda, V. I., Piazza, N. J., Devlin, M., Ritchie, M. H., Salyers, K., & Tucker-Gail, K. (2016). Psychopharmacology in counseling, psychology, and social work education: An interdisciplinary history and implications for professional counselors. Wisconsin Counseling Association Journal, 29, 35–48. Sharma, V., Madaan, R., Bala, R., Goyal, A., & Sindhu, R. K. (2021). Pharmacodynamic and pharmacokinetic interactions of herbs with prescribed drugs: A review. Plant Archives, 21(1), 185–198. https://doi.org/10.51470/PLANTARCHIVES.2021.v21.S1.033 Shinjyo, N., Waddell, G., & Green, J. (2020). Valerian root in treating sleep problems and associated disorders—A systematic review and meta-analysis. Journal of Evidence-Based Integrative Medicine, 25, 1–31. https://doi.org/10.1177/2515690X20967323 Sidhu, G., & Marwaha, R. (2021). Phenelzine. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/ NBK554508 Singh, P., Srivastava, B., Kumar, A., & Dubey, N. K. (2008). Fungal contamination of raw materials of some herbal drugs and recommendation of Cinnamomum camphora oil as herbal fungitoxicant. Microbial Ecology, 56(3), 555–560. https://doi.org/10.1007/s00248-008-9375-x Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019). Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics, 16(3), 666–674. https://doi.org/10.1007/s13311-019-00767-8 Smith, T., Kawa, K., Eckl, V., Morton, C., & Stredney, R. (2017). Herbal supplement sales in US increase 7.7% in 2016: Consumer preferences shifting toward ingredients with general wellness benefits, driving growth of adaptogens and digestive health products. HerbalGram, 115, 56–65. https://www.herbalgram.org/ media/15603/hg115-mktrpt.pdf Solas, M., Puerta, E., & Ramirez, M. J. (2015). Treatment options in Alzheimer’s disease: The GABA story. Current Pharmaceutical Design, 21(34), 4960–4971. https://doi.org/10.2174/1381612821666150914121149 Spindle, T. R., Cone, E. J., Kuntz, D., Mitchell, J. M., Bigelow, G. E., Flegel, R., & Vandrey, R. (2020). Urinary pharmacokinetic profile of cannabinoids following administration of vaporized and oral cannabidiol and vaporized CBD-dominant cannabis. Journal of Analytical Toxicology, 44(2), 109–125. https://doi.org/10.1093/jat/bkz080
RkJQdWJsaXNoZXIy NDU5MTM1